Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jun 13;6(1):59–69. doi: 10.1016/j.bpsc.2020.06.003

Table 1.

Demographic participant details grouped by familial risk status, and ASD symptoms at 18 months.

Familial Risk (N=36) Low Risk (N=29) P Valuea ASD+ (N=14) ASD− (N=51) P Valuea


Sex 13 f 11 f .54 2 22 0.60
n female (% female) (36.1%) (37.9%) (14.3%) (43.1%)
Race n (%)
White 21 (58.3%) 18 (62.1%) .21 4 (28.6%) 35 (68.6%) .01*
More than one race 9 (25%) 10 (34.5%) 6 (42.9%) 13 (25.5%)
Asian/Black/Pacific Islander 6 (16.7%) 1 (3.4%) 4 (28.6%) 3 (5.9%)
Ethnicity n (%)
Hispanic 16 (44.4%) 4 (13.8%) .01* 5 (35.7%) 15 (29.4%) .65
Non-Hispanic 20 (55.6%) 25 (86.2%) 9 (64.3%) 36 (70.6%)
Maternal Education n (%)
Some college or less 2 (6.9%) 2 (6.9%) .756 2 (14.3%) 2 (3.9%) .20
College Degree and above 28 (77.8%) 24 (82.8%) 9 (64.3%) 43 (84.3%)
Unreported 6 (16.7%) 3 (10.3%) 3 (21.4%) 6 (11.8%)
Precise 3 Month EEG age
Mean (SD), Range
3.18 (0.35), 2.57–3.90 3.17 (0.32), 2.63–4.13 .87 3.05 (.23), 2.57–3.43 3.21 (.36), 2.63–4.13 .117
18 Month MSEL Verbal T-score
Mean (SD), Range
43.39 (9.61), 21–63.5 49.07 (10.63), 25–66 .030* 31.75 (5.82), 21–40.50 49.95 (7.43), 35.5–66 <.001*
18 Month MSEL Non-verbal T-score.
Mean (SD), Range
46.07 (7.51), 24.5–64 51.54 (9.08), 25–66 .011* 40.96 (9.70), 24.5–59.5 50.65 (7.02), 34–66 <.001*
18 Month ADOS-T Total Score
Mean (SD), Range
7.17 (5.12), 1–18 5.21 (4.44), 0–18 .11 14.28 (2.67), 10–18 4.09 (2.46), 0–9 <.001*
18Month ADOS-T Total Score >10
n >10 (%>10)
11 (30.6%) 3 (10.3%) .07
a

Group differences assessed using independent samples t-tests or chi-square analyses.